Baumann, R. P., Penketh, P. G., Ishiguro, K., Shyam, K., Zhu, Y. L., & Sartorelli, A. C. (2009). Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance.

Baumann, Raymond P., Philip G. Penketh, Kimiko Ishiguro, Krishnamurthy Shyam, Yong L. Zhu, and Alan C. Sartorelli. Reductive Activation of the Prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) Selectively Occurs in Oxygen-deficient Cells and Overcomes O(6)-alkylguanine-DNA Alkyltransferase Mediated KS119 Tumor Cell Resistance. 2009.

Baumann, Raymond P., et al. Reductive Activation of the Prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) Selectively Occurs in Oxygen-deficient Cells and Overcomes O(6)-alkylguanine-DNA Alkyltransferase Mediated KS119 Tumor Cell Resistance. 2009.